Matches in Nanopublications for { ?s ?p ""Fenoglide is contraindicated in patients with severe renal dysfunction, including those receiving dialysis [see Clinical Pharmacology (12.3) Fenoglide is contraindicated in patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.1) Fenoglide is contraindicated in patients with gallbladder disease [see Warnings and Precautions (5.2) Fenoglide is contraindicated in nursing mothers [see Use in Specific Populations (8.3) Fenoglide is contraindicated in patients who have a known hypersensitivity to fenofibrate, such as severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis. [see Warnings and Precautions (5.9) Severe renal dysfunction, including patients receiving dialysis ( 4 12.3 Active liver disease ( 4 5.1 Gallbladder disease ( 4 5.2 Nursing mothers ( 4 8.3"" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""Fenoglide is contraindicated in patients with severe renal dysfunction, including those receiving dialysis [see Clinical Pharmacology (12.3) Fenoglide is contraindicated in patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.1) Fenoglide is contraindicated in patients with gallbladder disease [see Warnings and Precautions (5.2) Fenoglide is contraindicated in nursing mothers [see Use in Specific Populations (8.3) Fenoglide is contraindicated in patients who have a known hypersensitivity to fenofibrate, such as severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis. [see Warnings and Precautions (5.9) Severe renal dysfunction, including patients receiving dialysis ( 4 12.3 Active liver disease ( 4 5.1 Gallbladder disease ( 4 5.2 Nursing mothers ( 4 8.3"" assertion.